Compounds > methionine methyl ester
Page last updated: 2024-08-24

methionine methyl ester and Local Neoplasm Recurrence

methionine methyl ester has been researched along with Local Neoplasm Recurrence in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Souza, MM; Jaimini, A; Kaur, P; Mishra, A; Mondal, A; Panwar, P; Saw, S; Sharma, R; Tripathi, RP1
Beppu, T; Kato, K; Ogasawara, K; Sasaki, M; Sasaki, T; Sato, Y; Terasaki, K; Tomabechi, M1
Astner, ST; Grosu, AL; Heinemann, F; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA; Wester, HJ; Wiedenmann, N1
Kumabe, T; Shirane, R; Sonoda, Y; Takahashi, T; Yoshimoto, T1
Fujita, H; Higano, S; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Shishido, F; Uemura, K; Yasui, N1

Other Studies

5 other study(ies) available for methionine methyl ester and Local Neoplasm Recurrence

ArticleYear
11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Brain Neoplasms; Carbon Radioisotopes; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2014
MRI and 11C-methyl-L-methionine PET Differentiate Bevacizumab True Responders After Initiating Therapy for Recurrent Glioblastoma.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Temozolomide; Treatment Outcome; Young Adult

2016
An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    International journal of radiation oncology, biology, physics, 2011, Nov-15, Volume: 81, Issue:4

    Topics: Brain; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tumor Burden; Tyrosine

2011
Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Neurologia medico-chirurgica, 1998, Volume: 38, Issue:6

    Topics: Adult; Brain; Brain Neoplasms; Carbon Radioisotopes; Cranial Irradiation; Diagnosis, Differential; Female; Glioma; Humans; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Injuries; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1998
Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
    Acta radiologica (Stockholm, Sweden : 1987), 1991, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Brain; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiography; Radiotherapy; Tomography, Emission-Computed; Vitamin U

1991